1974•Journal of International Medical ResearchRequires access

A Double-Blind Trial of Bradilan (Tetranicotinoylfructose) in Perniosis in General Practice

F de S Donnan

Abstract

An initial double-blind cross-over study and a subsequent double-blind comparative study against placebo tablets has shown Bradilan (tetranicotinoylfructose) to be an effective treatment of chilblains. The difference between the active and placebo group was highly significant statistically with p < ·001

About this research paper

What this paper is about

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Double blind, Placebo, Double blind study, Internal medicine, Alternative medicine, Pathology